N- (2- (diethylamino)ethyl)- 2- methyl- 7- (1,2- dihydro- 5- fluoro- 2- oxo- 3H- indol- 3- ylidene)- 4,5,6,7- tetrahydro- 1H- indole- 3- carboxamide
a receptor tyrosine kinase inhibitor with antiangiogenic and antineoplastic activities; structure in first source
Also Known As:
N-(2-(diethylamino)ethyl)-2-methyl-7-(1,2-dihydro-5-fluoro-2-oxo-3H-indol-(Z)-3-ylidene)-4,5,6,7-tetrahydro-1H-indole-3-carboxamide; SIM 010603; SIM-010603; SIM010603; tafetinib
Networked: 2
relevant articles (0 outcomes,
1 trials/studies)
Bio-Agent Context: Research Results
Experts
1. | Lu, Guocai:
1 article
(05/2012)
|
2. | Mao, Yu:
1 article
(05/2012)
|
3. | Xia, Zhenna:
1 article
(05/2012)
|
4. | Yuan, Bojun:
1 article
(05/2012)
|
5. | Zhang, Xiaofang:
1 article
(05/2012)
|
6. | Zhu, Lin:
1 article
(05/2012)
|
7. | Zong, Ying:
1 article
(05/2012)
|
8. | Jiang, Zhenzhou:
1 article
(01/2012)
|
9. | Tang, Feng:
1 article
(01/2012)
|
10. | Wang, Dongchun:
1 article
(01/2012)
|
Related Diseases
Related Drugs and Biologics